Jérôme Galon
Immunology · 2002–2023
A researcher in the Science corpus: 21 papers; trusts 11 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 290 citations into it; #876 of 2,160 by trust here, #88 by citations
- Oncology — 279 citations into it; #567 of 1,698 by trust here, #57 by citations
- Molecular Biology — 146 citations into it
- Cancer Research — 59 citations into it
Whom Jérôme Galon trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Franck Pagès
- Bernhard Mlecnik
- Michael R. Kosorok
- Ana Kozomara
- Gabriela Bindea
- L. Galluzzi
- Robert Schreiber
- S. Topalian
- L. Zitvogel
- D. Gabrilovich
Who trusts Jérôme Galon overall
- Lieping Chen
- L. Zitvogel
- I. Mellman
- E. Batlle
- Bernhard Mlecnik
- Franck Pagès
- G. Dunn
- Xue Han
- Daniela Bruni
- Joel H. Saltz
Papers from Jérôme Galon's perspective
Ordered by how strongly the researchers Jérôme Galon trusts endorse each paper. Same corpus, a different order for every researcher.
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
- Hallmarks of cancer: the next generation. (Cell)
- In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. (Journal of Clinical Oncology)
- American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. (Journal of Clinical Oncology)
- Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. (New England Journal of Medicine)
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes (Clinical Cancer Research)
- Cancer-related inflammation (Nature)
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy (Nature Medicine)
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy (Nature Medicine)
- Natural innate and adaptive immunity to cancer. (Annual Review of Immunology)
Their papers
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks (2009) — 5,809 citations
- Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma (2023)
- Germline genetic contribution to the immune landscape of cancer (2021)
- The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy (2020) — 1,336 citations
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies (2019) — 2,840 citations
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. (2018) — 1,778 citations
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability. (2016) — 930 citations
- Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer (2015) — 1,071 citations
- Consensus guidelines for the detection of immunogenic cell death (2014) — 787 citations
- The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. (2013) — 811 citations
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours (2013) — 1,350 citations
- Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. (2013) — 3,752 citations
- CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data (2013) — 1,017 citations
- Cancer classification using the Immunoscore: a worldwide task force (2012) — 795 citations
- The immune contexture in human tumours: impact on clinical outcome (2012) — 4,576 citations
- Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. (2011) — 988 citations
- Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. (2011) — 1,129 citations
- In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. (2009) — 948 citations
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (2006) — 6,362 citations
- Effector memory T cells, early metastasis, and survival in colorectal cancer. (2005) — 2,124 citations